Shopping Cart
Remove All
Your shopping cart is currently empty
EBI-2511 is a highly potent, orally active inhibitor of EZH2, with an IC50 of 6 nM in Pfeffiera cell lines.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $52 | In Stock | In Stock | |
| 5 mg | $123 | In Stock | In Stock | |
| 10 mg | $197 | In Stock | In Stock | |
| 25 mg | $372 | In Stock | In Stock | |
| 50 mg | $579 | In Stock | In Stock | |
| 100 mg | $823 | - | In Stock | |
| 200 mg | $1,090 | - | In Stock |
| Description | EBI-2511 is a highly potent, orally active inhibitor of EZH2, with an IC50 of 6 nM in Pfeffiera cell lines. |
| Targets&IC50 | EZH2:6 nM (in cell) |
| In vitro | EBI-2511 obviously decreases cellular H3K27me3 levels in a dose-dependent manner (an approximate IC50: 8 nM) and it is 3-fold more potent than EPZ-6438. In addition to Pfeffier cell line, EBI-2511 was shown active against WSU-DLCL2 ( IC50: 55 nM) [1]. |
| In vivo | EBI-2511 demonstrates dose-dependent tumor growth inhibition, with tumor size reductions of 28% (10mg/kg), 83% (30mg/kg), and 97% (100mg/kg). No significant changes in body weights are observed across all treatment groups. At the same dosage, EBI-2511 shows superior anti-tumor efficacy compared to EPZ-6438 (P<0.01) [1]. |
| Molecular Weight | 576.77 |
| Formula | C34H48N4O4 |
| Cas No. | 2098546-05-3 |
| Smiles | CCN(C1CCOCC1)c1cc2oc(cc2c(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1CC)C1CCN(CC1)C(C)C |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||
| Solubility Information | DMSO: 5 mg/mL (8.67 mM), Sonication is recommended. | |||||||||||||||
Solution Preparation Table | ||||||||||||||||
DMSO
| ||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.